版本:
中国

BRIEF-Jazz Pharma says gave Roxane non-exclusive license under Xyrem patents to produce generic sodium oxybate product

April 5 Jazz Pharmaceuticals Plc

* Jazz Pharma - also gave Roxane non-exclusive license under Xyrem patents to make, market its generic sodium oxybate product under Roxane ANDA in Territory Source text: (bit.ly/2p2w878) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐